Literature DB >> 24634005

Association between reperfusion and shrinkage percentage of the aneurysmal sac after embolization of pulmonary arteriovenous malformation: evaluation based on contrast-enhanced thin-section CT images.

Satoko Makimoto1, Takao Hiraki, Hideo Gobara, Hiroyasu Fujiwara, Toshihiro Iguchi, Yusuke Matsui, Hidefumi Mimura, Susumu Kanazawa.   

Abstract

PURPOSE: To investigate an association between reperfusion and the percentage of shrinkage of the aneurysmal sac after embolization of pulmonary arteriovenous malformation (PAVM) and to determine the cutoff value of the shrinkage percentage for indicating reperfusion.
MATERIALS AND METHODS: Twenty-two PAVMs with completely embolized feeding arteries with coils were examined. The percentage of sac shrinkage and the presence of reperfusion were evaluated on computed tomography before and 1, 3, and 12 months after embolization. The percentages of sac shrinkage were compared between the occlusion and reperfusion groups. The receiver-operating characteristic (ROC) curve was generated to determine the diagnostic efficiency of reperfusion of PAVM by using shrinkage percentages.
RESULTS: Reperfusion was seen in 14, 13, and 11 lesions at 1, 3, and 12 months, respectively. The mean percentage of sac shrinkage was significantly different between the two groups at 3 and 12 months. The area under the ROC curve was 0.991 at 3 months and 0.934 at 12 months. All 9 lesions with <60% sac shrinkage at 12 months showed reperfusion.
CONCLUSION: The percentage of sac shrinkage was closely associated with reperfusion after embolization of PAVMs at 3 and 12 months. A shrinkage percentage of <60% at 12 months indicated reperfusion.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24634005     DOI: 10.1007/s11604-014-0301-5

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  18 in total

Review 1.  Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms.

Authors:  C L Shovlin; M Letarte
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

2.  Clinical and anatomic outcomes after embolotherapy of pulmonary arteriovenous malformations.

Authors:  Jeffrey S Pollak; Sanjay Saluja; Ashraf Thabet; Katharine J Henderson; Neil Denbow; Robert I White
Journal:  J Vasc Interv Radiol       Date:  2006-01       Impact factor: 3.464

3.  Recanalization after coil embolotherapy of pulmonary arteriovenous malformations: study of long-term outcome and mechanism for recanalization.

Authors:  K Sagara; N Miyazono; H Inoue; K Ueno; H Nishida; M Nakajo
Journal:  AJR Am J Roentgenol       Date:  1998-03       Impact factor: 3.959

4.  Embolotherapy of pulmonary arteriovenous malformations with detachable balloons: long-term durability and efficacy.

Authors:  S Saluja; I Sitko; D W Lee; J Pollak; R I White
Journal:  J Vasc Interv Radiol       Date:  1999 Jul-Aug       Impact factor: 3.464

5.  Clinical and radiological long-term follow-up after embolization of pulmonary arteriovenous malformations.

Authors:  Poul Erik Andersen; Anette D Kjeldsen
Journal:  Cardiovasc Intervent Radiol       Date:  2006 Jan-Feb       Impact factor: 2.740

6.  Pulmonary arteriovenous fistulas: Mayo Clinic experience, 1982-1997.

Authors:  K L Swanson; U B Prakash; A W Stanson
Journal:  Mayo Clin Proc       Date:  1999-07       Impact factor: 7.616

7.  Pulmonary arteriovenous malformations: cerebral ischemia and neurologic manifestations.

Authors:  M Moussouttas; P Fayad; M Rosenblatt; M Hashimoto; J Pollak; K Henderson; T Y Ma; R I White
Journal:  Neurology       Date:  2000-10-10       Impact factor: 9.910

8.  Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy.

Authors:  R I White; A Lynch-Nyhan; P Terry; P C Buescher; E J Farmlett; L Charnas; K Shuman; W Kim; M Kinnison; S E Mitchell
Journal:  Radiology       Date:  1988-12       Impact factor: 11.105

9.  Embolotherapy of pulmonary arteriovenous malformations: long-term results in 112 patients.

Authors:  Johannes J Mager; Timotheus T C Overtoom; Hylke Blauw; Jan W J Lammers; Cornelius J J Westermann
Journal:  J Vasc Interv Radiol       Date:  2004-05       Impact factor: 3.464

10.  Cerebral embolism--first manifestation of pulmonary arteriovenous malformation in patients with hereditary hemorrhagic telangiectasia.

Authors:  R C Hewes; M Auster; R I White
Journal:  Cardiovasc Intervent Radiol       Date:  1985       Impact factor: 2.740

View more
  6 in total

1.  Utility of second-generation single-energy metal artifact reduction in helical lung computed tomography for patients with pulmonary arteriovenous malformation after coil embolization.

Authors:  Yudai Asano; Akihiro Tada; Takayoshi Shinya; Yoshihisa Masaoka; Toshihiro Iguchi; Shuhei Sato; Susumu Kanazawa
Journal:  Jpn J Radiol       Date:  2018-02-10       Impact factor: 2.374

Review 2.  Embolisation for pulmonary arteriovenous malformation.

Authors:  Charlie C-T Hsu; Gigi Nc Kwan; Hannah Evans-Barns; Mieke L van Driel
Journal:  Cochrane Database Syst Rev       Date:  2018-01-04

Review 3.  Diagnosis and endovascular management of pulmonary arteriovenous malformations.

Authors:  Harshit Kramdhari; Jineesh Valakkada; Anoop Ayyappan
Journal:  Br J Radiol       Date:  2021-05-26       Impact factor: 3.629

4.  Ultra-short echo time magnetic resonance imaging for detection of pulmonary arteriovenous malformation recanalization after coil embolization: a case report and a phantom study.

Authors:  Kohei Hamamoto; Emiko Chiba; Katsuhiko Matsuura; Tomohisa Okochi; Keisuke Tanno; Osamu Tanaka
Journal:  Acta Radiol Open       Date:  2017-09-14

5.  Where is the Origin of the Last Normal Branch from Feeding Artery of Pulmonary Arteriovenous Malformations?

Authors:  Miyuki Maruno; Hiro Kiyosue; Norio Hongo; Shunro Matsumoto; Hiromu Mori
Journal:  Cardiovasc Intervent Radiol       Date:  2018-08-22       Impact factor: 2.740

6.  Feasibility of Non-contrast-enhanced MR Angiography Using the Time-SLIP Technique for the Assessment of Pulmonary Arteriovenous Malformation.

Authors:  Kohei Hamamoto; Katsuhiko Matsuura; Emiko Chiba; Tomohisa Okochi; Keisuke Tanno; Osamu Tanaka
Journal:  Magn Reson Med Sci       Date:  2016-02-03       Impact factor: 2.471

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.